Comparative assessment of the activity of beta-carotene, retinoyl-beta-D-glucuronide and retinoic acid on growth and differentiation of a human promyelocytic leukemia cell line HL-60

International Journal for Vitamin and Nutrition Research

Volumn 67, Issue 5, 1997, Pages 357-363

  Biesalski, Hans Konrad ^a,b   Schäffer, Michael ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

^b UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

Carotene retinoyl glucuronides; Chemiluminesce nce; Differentiation HL 60; Retinoids

Indexed keywords

ANTIOXIDANT; BETA CAROTENE; DRUG DERIVATIVE; RETINOIC ACID; RETINOIC ACID GLUCURONIDE;

ARTICLE; CELL DIVISION; CELL STRAIN HL 60; CELL SURVIVAL; CELL TRANSFORMATION; COMPARATIVE STUDY; DRUG EFFECT; HUMAN; PHYSIOLOGY; TIME;

ANTIOXIDANTS; BETA CAROTENE; CELL DIVISION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; HL-60 CELLS; HUMANS; TIME FACTORS; TRETINOIN;

EID: 1842326160     PISSN: 03009831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Roberts, A. B. and Sporn, M. B. (1984) Cellular biology and biochemistry. In: The retinoids (Sporn, M. B., Roberts, A. B. and Goodman, D. S., eds.) pp. 209-287, Academic Press, Orlando (FL).
2. Olson, J. A. (1994) Vitamin A, retinoids and carotenoids. In: Health and Disease, 8th Ed. (Sils, M. E., Olson, J. A. and Shike, M., eds.) pp. 178-209, Lea & Febiger, Philadelphia.
3. Bollag, W. and Matter, A. (1981) From vitamin A to retinoids in experimental and clinical oncology: achievements, failures, and outlook. Ann. N. Y. Acad. Sci. 359, 9-23.
4. Biesalski, H. K., Doepner, G., Kun, H., Paust, J. and John, M. (1995) Convenient synthesis of biologically important retinoids. Liebigs Ann. 717-720.
5. Biesalski, H. K., Doepner, G. and Gerharz, C. D. (1993) All-trans retinyl- and all-trans retinoyl-β-D-glucuronides: synthesis, pharmacology and biological activity. In: Retinoids (Livrea, M. A. and Parker, L., eds.) pp. 329-339, Marcel Dekker, New York.
6. Collins, S. J. (1987) The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood 70, 1233-1244.
7. Breitman, T. R. (1990) Growth and differentiation of human myeloid leukemia cell line HL-60. In: Methods in Enzymology. (Packer, L., ed.) 190, pp. 118-130, Academic Press, San Diego (CA).
8. Allen, R. C. (1986) Phagocytic leukocyte oxygenation activity and chemiluminescence: A kinetic approach to analysis. In: Methods in Enzymology. (DeLucca, A., ed.) 133 pp. 449-493, Academic Press, San Diego (CA).
9. Van Dyke, K. and Van Dyke, C. (1986) Cellular chemiluminescence associated with disease states. In: Methods in Enzymology. (DeLucca, A., ed.) 133, pp. 494-507, Academic Press; San Diego (CA).
10. Doepner, G. and Biesalski, H. K. (1992) Effects of novel retinoids on growth and differentiation of a rhabdomyosarcoma cell line. Arzneimittel-Forsch/Drug Res. 42, 1036-1040.
11. Biesalski, H. K., Gabbert, H. E., Gerharz, C. D., Engers, R. and Brodda, K. (1990) Uptake and metabolism of retinoic acid induces inhibition of cell growth: A study in a rat rhabdomyosarcoma cell line (BA-HAN-1C) using nonlinear theoretical models. Internat. J. Vit. Nutr. Res. 60, 6-17.
12. Chomienne, C., Ballerini, P., Balitrand, N., Daniel, M. T., Fenaux, P., Castaigne, S. and Degos, L. (1990) All trans retinoic acid in promyelocytie leukemias. II. In vitro studies structure function relationship. Blood 76, 1710-1717.
13. Scale, J., Delva, L., Renesto, P., Balitrand, N., Dombret, H., Scrobohaci, M. L., Degos, L., Paul, P. and Chomienne, C. (1996) All-trans retinoic acid rapidly decreases cathepsin G synthesis and mRNA expression in acute promyelocytic leukemia. Leukemia 10, 95-101.
14. De Gentile, A., Toubert, M. E., Dubois, C., Krawice, I., Schlageter, M. H., Balitrand, N., Castaigne, S., Degos, L., Rain, J. D., Najean, Y. and Chomienne, C. (1994) Induction of high-affinity GM-CSF receptors during all trans retinoic acid treatment of acute promyelocytie leukemia. Leukemia 8, 1758-1762.
15. Dubois, C., Schlageter, M. H., De Gentile, A., Guidez, F., Balitrand, N., Toubert, M. E., Krawice, I., Fenaux, P., Castaigne, S., Najean, Y., Degos, L. and Chomienne, C. (1994) Modulation of II-6 and II-1β and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia. Leukemia 8, 1750-1757.
16. Chambon, P. (1996) A decade of molecular biology of retinoic acid receptors. FASEB J. 10, 940-954.
17. De Thé, H., Lavau, C., Marchino, A., Chomienne, C., Degos, L. and Dejean, A. (1991) The PML-RAR alpha fusion mRNA generated by the t(15; 17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66, 675-684.
18. Kakizuka, A., Miller, W. H., Umesono, K., Warrell, R., Frankel, S., Dmitrovsky, E. and Evans, R. (1991) Chromosomal translocation t(15; 17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor. PML. Cell 66, 663-674.
19. Rousselot, P., Hardas, B., Castaigne, S., Dejean, A., de Thé, H., Degos, L., Farzaneh, F. and Chomienne, C. (1994) The PML-RARα gene product of the t(15; 17) translocation inhibits retinoic acid induced granulocytic differentiation. Oncogene 9, 545-551.
20. Chen, Z., Guidez, F., Rousselot, P., Agadir, A., Chen, S. J., Wang, Z. Y., Degos, L., Waxman, S., Zellent, A. and Chomienne, C. (1994) PLZF-RAR fusion protein generated from the translocation t(11; 17) (q23:q21) displays altered transactivation properties against the wildtype retinoic acid receptors. Proc. Natl. Acad. Sci. USA 91, 1178-1182.
21. Koken, M. H. M., Puvion-Dutilleuil, F., Guillemin, M. C., Viron, A., Linares-Cruz, G., Stuurman, N., de Jong, L., Szostecki, C., Calvo, F., Chomienne, C., Degos, L., Puvion, E. and de Thé, H. (1994) The t(15; 17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J. 13, 1073-1083.
22. Jannick-Buckner, D., Barua, A. B. and Olsen, J. A. (1991) Induction of HL-60 differentiation by watersoluble and nitrogen-containing conjugates of retinoic acid and retinol. FASEB J. 5, 320-325.
23. Zile, M. H., Cullum, M. E., Simpson, R. U., Barua, A. B. and Swartz, D. A. (1987) Induction of differentiation of human promyelocytic leukemia cell line HL-60 by retinoyl-glucuronide, a biologically active metabolite of vitamin A. Proc. Natl. Acad. Sci., USA 84, 2208-2212.
24. Sani, B. P., Barua, A. B., Hill, D. L., Shin, T. W. and Olsen, J. A. (1992) Retinoyl-beta-D-glucuronide: lack of binding to receptor protein of retinoic acid as related to biological activity. Biochem. Pharmacol. 43, 919-922.
25. Takahashi, N. and Breitman, T. R. (1991) Retinoylation of proteins in leukemia, embryonal carcinoma, and normal kidney cell lines: differences associated with differential responses to retinoic acid. Arch. Biochem. Biophys. 285, 105-110.
26. Cooney, R. V. Kappock, T. J., Pung, A. and Bertram, J. S. (1993) Solubilization, cellular uptake and activity of beta-carotene and other carotenoids as inhibitors of neoplastic transformation in cultured cells. In: Methods in Enzymology. (Packer, L., ed.) 214, pp. 55-68. Academic Press, San Diego (CA).
27. Napoli, J. L. and Race, K. R. (1988) Biogenesis of retinoic acid from beta-carotene. J. Biol. Chem. 262, A372-A377.
28. Olsen, J. A. (1989) Provitamin A function of carotenoids: The conversion of beta-carotene into vitamin A. J. Nutr. 119, 105-108.
29. Wamer, W. O., Wei, R. R., Matusik, J. E., Kornhauser, A. and Dunkel, V. C. (1993) Beta-carotene uptake, metabolism, and distribution in BALB/C 3T3 cells. Nutr. Cancer 19 (1), 31-41.
30. Biesalski, H. K. (1990) Wirksamkeit von Beta-Carotin bei der Prävention von Krebs. Wunsch oder Wirklichkeit. Vita Min Spur, Supplement 1, 1-32.
31. Formelli, F., Barua, A. B. and Olson, J. A. (1996) Bioactivities of N-(4-hydroxyphenyl) retinamide and retinoyl β-glucuroide. FASEB J. 10, 1014-1024.